Condition: Atrial Fibrillation and Flutter · Stroke · Major Bleed · Sponsor: Nicholas Carlson
The study aims to evaluate the appropriateness of initiating oral anticoagulation for stroke risk reduction in dialysis populations with atrial fibrillation. Specifically, the study will assess the overall safety, tolerability, and efficacy of initiating treatment with Warfarin in patients with end-stage renal disease on dialysis and atrial fibrillation.
This description comes directly from the study's public registry record.
Nicholas Carlson, MD PhD Ass. Prof · +45 35455927 · nicholas.carlson.01@regionh.dk
Ellen LF Ballegaard, MD PhD · ellen.linnea.freese.ballegaard@regionh.dk
Always discuss trial participation with your own doctor first.
| Department of Nephrology, Herlev Hospital | Herlev, Herlev, Denmark | Recruiting |
| Department of nephrology, Nordsjaellands Hospital | Hillerød, Hillerød, Denmark | Recruiting |
| Aalborg University Hosptial | Aalborg, Denmark | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Department of Nephrology, Copenhagen University Hospital Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Esbjerg and Grindsted Hospital | Esbjerg, Denmark | Recruiting |
| Holbaek Hospital | Holbæk, Denmark | Recruiting |
| Holstebro Hospital | Holstebro, Denmark | Recruiting |
| Lillebælt Hospital | Kolding, Denmark | Recruiting |
| Zealand University Hospital | Roskilde, Denmark | Recruiting |
| Bornholms Hospital | Rønne, Denmark | Recruiting |
| Hospital Sønderjylland | Sønderborg, Denmark | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03862859